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Transcription-driven DNA methylation setting on the mouse Peg3 locus
Corey L. Bretz and Joomyeong Kim
Department of Biological Sciences, Louisiana State University, Baton Rouge, LA, USA

ABSTRACT

The imprinting of the mouse Peg3 domain is controlled through the Peg3-DMR, which obtains its maternalspeciﬁc DNA methylation during oogenesis. In the current study, we deleted an oocyte-speciﬁc alternative
promoter, termed U1, which is localized 20 kb upstream of the Peg3-DMR. Deletion of this alternative
promoter resulted in complete removal of the maternal-speciﬁc DNA methylation on the Peg3-DMR.
Consequently, the imprinted genes in the Peg3 domain become biallelic in the mutants with maternal
transmission of the deletion. Expression levels of the imprinted genes were also affected in the mutants: 2fold upregulation of Peg3 and Usp29 and downregulation of Zim1 to basal levels. Breeding experiments
further indicated under-representation of females among the surviving mutants, a potential sex-biased
outcome from the biallelic expression of the Peg3 domain. Overall, the results suggest that U1-driven
transcription may be required for establishing oocyte-speciﬁc DNA methylation on the Peg3 domain.
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Introduction
Paternally expressed gene 3 (Peg3) is the founding member
of the mammalian Peg3 imprinted domain, which covers an
evolutionarily well-conserved 500-kb genomic region in
human chromosome 19q13.4/proximal mouse chromosome
7.1 This domain contains paternally expressed Peg3, Usp29,
APeg3, Zfp264, and maternally expressed Zim1, Zim2,
Zim3.2 The Peg3 domain is controlled through an imprinting control region (ICR) termed the Peg3-differentially
methylated region (DMR).3 The Peg3-DMR covers a 4-kb
genomic region that harbors a bidirectional promoter for
Peg3 and Usp29 and also the 1st intron region of Peg3 with
a tandem array of 7 YY1 binding sites.4 According to recent
results, deletion of this ICR resulted in global changes in
the transcriptional levels and monoallelic expression patterns of the entire domain, conﬁrming that this region is
indeed a major controlling factor for the Peg3 domain.5 The
Peg3-DMR obtains DNA methylation as a gametic signal
during oogenesis, and maintains its maternal-speciﬁc methylation pattern throughout the lifetime of mammals. It is,
however, currently unknown how this ICR obtains DNA
methylation during oogenesis.
Results from the study of Gnas, Zac1, Snrpn, and Kcnq1
imprinted domains suggest that alternative promoters may be
involved in the targeting process of DNA methylation to
ICRs.6-10 In these imprinted domains, alternative promoters

are functional during oogenesis, subsequently triggering
transcription. Also, these alternative promoters are all located
upstream of their ICRs, thus the transcription usually traverses through the ICRs during oogenesis. The passing of RNA
polymerase II has been shown to be important for setting up
oocyte-speciﬁc DNA methylation on the ICRs. Deletion of
the alternative promoters or truncation of the alternative
transcripts usually causes defects in the setting up of oocytespeciﬁc DNA methylation on the ICRs.6,9 Recent studies
further suggest that the recruitment of the de novo DNA
methyltransferase DNMT3A to ICRs may require two particular histone modiﬁcations, H3K4me0 and H3K36me3, which
are generated during the transcription elongation process by
RNA polymerase II.11
Transcription of Peg3 also involves three alternative promoters, termed U1, U2, and U3, which are localized 20, 26,
and 160 kb upstream of the Peg3-DMR, respectively.12
Among these, the alternative promoter U1 is functional in
oocytes.9,12 This suggests that this alternative promoter may
be involved in the DNA methylation of the downstream
main promoter, Peg3-DMR. In the current study, we tested
this possibility by generating and analyzing a mutant strain
lacking the alternative U1 promoter. Our results conﬁrm
that this alternative promoter is indeed required for the
establishment of oocyte-speciﬁc DNA methylation on the
Peg3-DMR.
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Results
Generation of a mutant allele by deletion
of the alternative promoter U1
To test the predicted function of U1, we deleted the genomic
region containing the U1 promoter using a CRISPR/Cas9based strategy (Figure 1A). We designed two single-stranded
guide RNA ﬂanking the 1-kb genomic region of the U1 promoter, and subsequently tested the feasibility of this deletion
strategy in vitro. After the initial conﬁrmation, these two guide
RNA were injected into 200 fertilized eggs of the C57BL/6J
background along with Cas9 mRNA. We obtained 45 live mice
from this initial set of injected eggs. Among these, 12 mice
were shown to be properly targeted by the two guide RNA
based on the results of PCR-based genotyping (Figure 1B). Ten
of these 12 mice showed an almost identical and predicted size
of PCR products, indicating proper deletion of the 1-kb region
as designed; this set of deleted alleles was named U1 deletion
regular (U1DR). In contrast, the other two mice showed a
20 bp larger and an 80 bp smaller deletion, named U1DL and
U1DS, respectively. The exact deleted regions within these
founder lines were further conﬁrmed via individual Sanger
sequencing (Sup_Fig 1). The exact boundaries of the deleted
regions are slightly different between the individual founders
since this CRISPR/Cas9-driven deletion scheme was based on
non-homologous end joining repair mechanism. Among these
founders, we selected ﬁve founders from the U1DR group for
further breeding experiments. All ﬁve founders successfully
transmitted their deleted alleles to the following generations
without major effects; therefore, these ﬁve lines have been
collectively regarded as a single line, the U1DR line, hereafter.
Through this initial set of breeding experiments, we

successfully established a deletion mutant line and also
obtained several litters of F1 and F2 with both paternal and
maternal transmission of the deleted allele. Using these mice,
we ﬁrst performed a series of RT-PCR detecting the transcript
driven by U1 (Figure 1C). Besides oocytes, the U1 promoter is
known to trigger transcription in the hypothalamus of adult
mice.11 Also, the U1 promoter is allele-speciﬁc, only functional
from the maternal allele.11 Thus, we prepared a set of total
RNA from the hypothalamus of adult mice that had inherited
the deleted allele maternally and paternally. As expected, the
U1 transcript was detected in the hypothalamus of both wild
type (WT) and mutants with paternal transmission (KOC/¡-P),
but not in mutants with maternal transmission (KO¡/C-M)
(Figure 1C). This observation conﬁrmed that the deletion
indeed abolished the transcriptional activity of the U1 promoter. In summary, we have successfully established a deletion
mutant line targeting the U1 promoter using a CRISPR/Cas9based strategy.
Effects of U1 deletion on Peg3-DMR methylation
We next tested the potential effects of U1 deletion on the DNA
methylation status of the Peg3-DMR (Figure 2). We prepared
two sets of genomic DNA: DNA from mature eggs and DNA
from somatic tissues. First, we isolated genomic DNA from two
sets of 3-month-old females: heterozygotes (KO) and WT littermates. Isolated DNA was bisulﬁte converted,13 and then
used for PCR ampliﬁcation followed by cloning and sequencing. These series of DNA methylation analyses targeted two
genomic regions: one within the Peg3-DMR and the other
within the Peg10-DMR (as a control). As expected, the DNA
methylation levels of the Peg10-DMR were close to 100% in

Figure 1. CRISPR/Cas9-based deletion of the U1 promoter. (A) Schematic representation of the Peg3 domain. Each imprinted gene is indicated with an arrow. Paternally
and maternally expressed genes are indicated in blue and red, respectively. The three DMRs are indicated with gray boxes. The relative position of the U1 promoter is
indicated with an arrow. The detailed genomic structure of U1 is also shown with the two single-stranded guide RNA for CRISPR/Cas9-based deletion, the positions of
which are indicated with green vertical arrows. The CRISPR/Cas9-based deletion derived the three representative mutant alleles, and their deleted regions are shown.
The arrows on the bottom indicate the three primers (P1, P2, P3) that were used for genotyping. (B) PCR-based genotyping of the deleted alleles. The three primers were
used together for genotyping: the combination of P1 and P2 primers targets the wild type allele (403 bp in length), whereas the combination of P1 and P3 primers targets
the deleted alleles (about 270 bp). (C) RT-PCR detecting the transcript driven by the U1 promoter. This series of analyses used a set of total RNA isolated from the hypothalamus of adult mice of three genotypes: WT, KO(¡/C)-M, and KO(C/¡)-P, the last two inheriting the deletion maternally and paternally, respectively.
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Figure 2. Effects of the U1 deletion on the DNA methylation levels of the Peg3-DMR. (A) A series of DNA methylation analyses were performed with DNA from mature
eggs isolated from two sets of 3-month-old females: WT and KO. Bisulﬁte-converted DNA was ampliﬁed with two sets of primers targeting Peg3-DMR and Peg10-DMR.
Ampliﬁed PCR products were subsequently analyzed by individual sequencing. Each square represents a CpG site with close and open squares indicating methylated and
unmethylated CpG, respectively. (B) A similar series of DNA methylation analyses were performed on a set of somatic DNA isolated from tails of WT and KO of both sexes
with maternal and paternal transmission of the U1 deletion. Ampliﬁed PCR products were analyzed by COBRA. Each target region was digested with enzymes that can differentiate the methylation status of the original DNA. The letter U or M indicates the unmethylation or methylation status, respectively, based on the digestion pattern by
a given restriction enzyme. The blue  indicates the mutational effects of the U1 deletion on the Peg3-DMR: removal of maternal-speciﬁc DNA methylation.

both WT and KO samples (Figure 2A), conﬁrming the purity of
the isolated eggs as well as the feasibility of the approach. In
contrast, DNA methylation levels of the Peg3-DMR were quite
different between the two samples: 65% in WT vs. 7% in KO.
The high levels of DNA methylation in WT were expected since
the Peg3-DMR is methylated during oogenesis. In contrast, the
signiﬁcantly lower levels in KO indicated a target-speciﬁc outcome by the deletion of U1, thus conﬁrming the predicted role
of U1 during oogenesis. We repeated this series of experiments
three times, including eggs set from the female homozygotes
(Sup_Fig 3), and the results were overall similar to those shown
in Figure 2A.
We also performed DNA methylation analyses using DNA
isolated from the tails of sets of WT and KO neonates of both
sexes with maternal and paternal transmission of the deletion
(Figure 2B). DNA was analyzed similarly as described above
except that DNA methylation levels were measured using combined bisulﬁte restriction analysis (COBRA).14 KO mice with
maternal transmission of the U1 deletion showed complete loss
of DNA methylation on the Peg3-DMR (see lanes 2 and 4 in
Figure 2B). We also tested several regions within the Peg3DMR, which, again, showed the same outcome: no DNA methylation within the Peg3-DMR. This agrees with the results from
mature eggs, showing very low levels of DNA methylation in
KO (Figure 2A). We repeated this series of DNA methylation
analyses using DNA isolated from F1 and F2 pups, totaling 48
carriers with maternal transmission: the majority of these pups
(35/48 D 72.3%) showed no methylation on the Peg3-DMR
(Sup_Fig 2), suggesting that the mutation is approximately
70% penetrant. In contrast, results from mice with paternal
transmission of the U1 deletion showed no major changes in
DNA methylation levels of the Peg3-DMR (see lanes 6 and 8 in
Figure 2B). This is consistent with the fact that transcription by
the U1 promoter is undetectable and non-functional during
spermatogenesis; therefore, the paternal transmission of the
deletion should not cause any effect. We also surveyed DNA
methylation levels of the three other regions within the Peg3

domain, including the promoter of Zim1 and the DMRs of
Zim2 and Zfp264/Zim3 (Figure 1A). However, we did not
observe any changes in these regions in either set of samples,
indicating no major effect on the DNA methylation levels of
the other DMRs within the Peg3 domain. Overall, this series of
DNA methylation analyses showed that deletion of U1 resulted
in signiﬁcant reduction in DNA methylation levels on the
Peg3-DMR during oogenesis and, in addition, that the majority
of the mutant mice inheriting the deletion maternally showed
no methylation on the Peg3-DMR.
Effects of U1 deletion on the imprinting status
of the Peg3 domain
The results described above were followed up with imprinting
tests. For this series of analyses, we prepared hybrid pups
derived from the reciprocal crossing between the KO of the
C57BL/6J(B6) background and WT of the PWD/PhJ(PWD)
background (Figure 3). Total RNA isolated from the neonatal
heads of the hybrids were used for generating cDNA, which
was subsequently used as template for amplifying several
imprinted genes within the Peg3 domain. The results are summarized as follows. The majority of the genes within the Peg3
domain became biallelic in mutants with maternal transmission
of the U1 deletion, including Peg3, Usp29, Zim1, and Zim2 (see
lane 4 in Figure 3). Transcription of these genes was also
derived equally from both alleles. Biallelic expression of Peg3
and Usp29 was expected, given no allele-speciﬁc DNA methylation was observed on their bidirectional promoter Peg3-DMR.
Biallelic expression of the other genes, Zim1 and Zim2, is also
consistent with the fact that the imprinting of these adjacent
genes is also co-regulated through the Peg3-DMR as an ICR
along with that of Peg3/Usp29. In contrast, paternal transmission of the U1 deletion did not cause any changes in the allelespeciﬁc expression patterns of the same set of genes, the exact
same patterns of allele-speciﬁc expression were observed in
WT and KO (compare lanes 5 and 6 in Figure 3). This agrees
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Figure 3. Effects of the U1 deletion on the imprinting status of the Peg3 domain. A
series of imprinting tests were performed with total RNA isolated from neonatal
heads of the F1 hybrid that had been prepared through the reciprocal crossing of
heterozygotes with the B6 background and the breeding partners with the PWD/
PhJ background. The products from RT-PCR were digested with a given restriction
enzyme to differentiate parental alleles, which are shown as different-sized DNA
fragments on gel images. The two columns on the left represent the digestion patterns for two parental strains for each gene; the two middle columns represent
results from the F1 hybrid set with maternal transmission of the U1 deletion
(female heterozygote with male PWD/PhJ); the two columns on the right represent
the results from the F1 hybrid set with paternal transmission of the U1 deletion
(female PWD/PhJ with male heterozygote). The blue  indicates the mutational
effects of the U1 deletion on the imprinting status of genes: biallelic expression.

with the observation that paternal transmission of the U1 deletion has no effects on the DNA methylation of the Peg3-DMR
(Figure 2B). Overall, this series of analyses demonstrated that
the removal of allele-speciﬁc DNA methylation on the Peg3DMR resulted in biallelic expression of the Peg3 domain.
Effects of U1 deletion on the expression levels
of the Peg3 domain
We also tested potential effects of the U1 deletion on the
expression levels of the imprinted genes within the Peg3
domain (Figure 4). This series of expression analyses used a set
of total RNA isolated from the neonatal heads of WT and KO
of both sexes with maternal transmission of the U1 deletion.
Isolated RNA was converted into cDNA, which was then used
for qRT-PCR. The expression levels of Peg3 and Usp29 were
signiﬁcantly upregulated in both sexes: 2.5- and 2.8-fold in
females and 1.9- and 2.5-fold in males, respectively (P value
<0.001). In contrast, expression levels of Zim1 were signiﬁcantly downregulated in both male and female KO, 3–5% of
WT levels (P value <0.001) (Figure 4A). It is relevant to note
that Zim1 is also normally expressed from the paternal allele,
but at very low levels relative to the levels of the maternal
allele.15 Thus, the biallelic expression of Zim1 observed in the
hybrid KO might be an outcome of a scenario in which the signiﬁcantly reduced expression levels of Zim1 from the maternal
allele became similar to the basal levels of the paternal allele,
thus showing the biallelic expression pattern (Figure 3). On the
other hand, the expression levels of Zfp264 were not affected in
either sex. We repeated a similar series of analyses using a set

Figure 4. Effects of the U1 deletion on the expression levels of the Peg3 domain.
Potential effects of the U1 deletion on the expression levels of the individual genes
were analyzed using a set of total RNA isolated from neonatal heads (A) and adult
hypothalamus (B) of WT and KO(¡/C) mice with maternal transmission of the
deletion. This series of qRT-PCR analyses tested four imprinted genes, Peg3, Usp29,
Zim1, and Zfp264. The expression levels of each gene were ﬁrst normalized with
an internal control (b-actin), and the subsequent value was compared between KO
and WT. The relative levels are presented with their standard deviation. This set of
analyses was repeated using two biological replicates.

of total RNA isolated from the hypothalamus of adult mice
(Figure 4B). The results were similar to those observed from
neonatal heads, except that the levels of upregulation observed
for both Peg3 and Usp29 were lower (1.5-fold) than those from
neonatal heads. Overall, these series of analyses concluded that
Peg3 and Usp29 were upregulated in the mutants with maternal
transmission of the U1 deletion. This is consistent with the
results showing loss of maternal-speciﬁc methylation of the
Peg3-DMR and subsequent biallelic expression of Peg3 and
Usp29.
Effects of U1 deletion on survival and growth rates
of the animals
Potential effects of the U1 deletion on the survival and growth
rates of the animals were tested with four individual breeding
experiments (Figure 5). Pups derived from these crosses were
analyzed in terms of their genotype, sex, and weight at birth:
First, the deletion of U1 did not cause any major effects on the
growth rates of the surviving animals, showing similar average
weights at neonatal and weaning ages among four individual
genotypes: WT(C/C), Heterozygote(Het)(¡/C), Het(C/¡),
and Homozygote (Hom)(¡/¡) (data not shown). This suggests
that the U1 deletion and subsequent biallelic expression of
Peg3/Usp29 may have minimal effects on the growth rates of
the surviving animals. Second, the U1 deletion did not cause a
signiﬁcant impact on the litter size of the animals. The four
breeding schemes showed similar litter sizes, ranging from 6.7
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Figure 5. Effects of the U1 deletion on survival. Four individual sets of breeding experiments were performed to test potential effects of the U1 deletion on survival (A-D).
The results from each breeding experiment were summarized with its average litter size, transmission ratios between individual genotypes, and sex ratios. The last row
(2X Peg3) summarizes the numbers of heterozygote and/or homozygote mice presumably having a double dosage of Peg3 as well as the imprinting defects, which were
measured by the DNA methylation status of the Peg3-DMR. Numbers in parentheses indicate the numbers of mice with 2X Peg3 and the imprinting defects in each genotype. Numbers in red indicate the unusual outcomes that deviate signiﬁcantly from the expected frequencies.

to 8.1. This indicates no obvious embryonic lethality associated
with these breeding schemes, especially during the postimplantation stage. Third, the number of homozygotes carrying
the U1 deletion were considerably smaller than the expected
frequencies from the two breeding schemes: for the Het £ Het
crossing, 3 were observed while 6.75 were expected; for the Het
£ Hom crossing, 4 were observed while 23.5 were expected
(P value <0.001) (Figure 5C and D). Fourth, the number of
female heterozygotes with maternal transmission of the U1
deletion was lower than that of male heterozygotes (18 vs. 30,
respectively) (Figure 5A). This became even more obvious
when we compared only the numbers of pups showing no
methylation on the Peg3-DMR (11 vs. 24, respectively; P value
<0.05), which presumably have a double (2X) gene dosage of
Peg3/Up29, as well as other imprinting defects. This implies
that females might be more susceptible to the biallelic expression and subsequent imprinting defects of the Peg3 domain. A
similar trend was also observed from the pups of the other
breeding scheme, for example, the four homozygotes from the
Het £ Hom crossing (Figure 5D). The DNA methylation status
on the Peg3-DMR in these homozygotes was variable between
the two sexes. The two male homozygotes showed no DNA
methylation, and were thus thought to have imprinting defects
of the Peg3 domain. In contrast, the two remaining female
homozygotes were still methylated with the U1 deletion, and
were thus thought to have normal imprinting of the Peg3
domain. This suggests that females may be more susceptible to
the imprinting defects of the Peg3 domain, in particular the 2X
gene dosage of Peg3. In summary, these series of breeding
experiments provided two new insights: (i) embryonic lethality
is associated with the homozygosity of the U1 deletion; (ii)
there is female-biased susceptibility to the imprinting defects of
the Peg3 domain.

Discussion
In the current study, we deleted the alternative promoter U1,
which is highly active during oogenesis, to test its potential role
in the establishment of DNA methylation on the Peg3-DMR.
As predicted, deletion of this alternative promoter indeed
caused complete removal of maternal-speciﬁc DNA methylation on the Peg3-DMR. As an outcome, the imprinted genes in
the Peg3 domain became biallelically expressed in mutants with
maternal transmission of the U1 deletion. The expression levels
of imprinted genes were also affected in the mutants; we
observed 2-fold upregulation of Peg3 and Usp29 and downregulation of Zim1 to basal levels (Figure 6). Breeding experiments
further revealed that females were under-represented among
the surviving mutants, a potential sex-biased outcome caused
by the biallelic expression of the Peg3 domain. Overall, the current study suggests that U1-driven transcription may be
required for establishing oocyte-speciﬁc DNA methylation on
the Peg3 domain.
Deletion of the U1 alternative promoter resulted in complete
removal of maternal-speciﬁc DNA methylation on the Peg3DMR (Figure 2). This is in agreement with results from other
imprinted domains, including the Gnas, Zac1, Snrpn, and Kcnq1
domains.6-10 Thus, oocyte-speciﬁc DNA methylation on the
Peg3-DMR is likely established through transcription-driven
recruitment of the de novo methyltransferase DNMT3A during
oogenesis.11 The results from the current study, however, provide
another insight that this transcription-mediated targeting process
may not be the only mechanism necessary for de novo DNA
methylation at the Peg3-DMR, since deletion of the U1 promoter
was about 70% penetrant in abolishing DNA methylation
imprint among mutant mice (Figure 5 and Sup_Fig 2). This
transcription-mediated mechanism might be one of several
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Figure 6. Summary of U1 deletion effects on imprinting and expression of the
Peg3 domain. A schematic representation of the Peg3 domain is shown on the
upper panel. Each imprinted gene is indicated with an arrow. Paternally and
maternally expressed genes are indicated in blue and red, respectively. Biallelically
expressed genes are indicated in gray. The position of ECR18, a potential enhancer,
is indicated with an oval. Mutational effects by maternal transmission of the U1
deletion are summarized from results derived from total RNA isolated from neonatal heads of both sexes. Paternal transmission of the U1 deletion did not cause any
major effects, thus omitted in this summary.

mechanisms involved in the targeting process of DNA methylation to ICRs, and other unknown mechanisms might compensate
the defects in the remaining 30% cases of de novo DNA methylation. This is further supported by the fact that the U1 transcript
has not been detected in oocytes from other mammals, such as
humans. In humans, the U1 promoter is, in fact, active in testis,
so that several transcripts driven by the U1 promoter are detected
in the Expressed Sequence Tags database. Consistent with this,
the DNA sequence of the U1 promoter itself seems to have
evolved very rapidly (data now shown), suggesting that U1 might
have adapted to slightly different roles in individual species.
Another possibility is that U1 might not be the only promoter
triggering transcription in the mice oocyte. Two additional alternative promoters, U2 and U3, are localized in the 200-kb
upstream region of the Peg3-DMR; however, these promoters
have not been shown to be functional in oocytes so far.12 Overall,
the current study, along with other studies, strongly suggests that
a transcription-driven mechanism may be the main mechanism
recruiting de novo DNA methylation to the ICRs.
Removal of the maternal-speciﬁc methylation on the Peg3DMR resulted in biallelic expression of the majority of
imprinted genes in the Peg3 domain (Figure 3 and 6). This
observation is noteworthy. First, in previous genetic studies on
genomic imprinting, genomic regions of the ICRs have been
deleted to test their predicted functions.16,17 In this situation, it
was difﬁcult to determine whether genomic sequences or allelespeciﬁc DNA methylation were more critical for the functions
of ICRs. According to the results from the U1 deletion, allelespeciﬁc DNA methylation on ICRs is more critical for the
imprinting of the Peg3 domain. Second, the de-repression of
Peg3 and Usp29 from the maternal allele appeared to coincide
with the signiﬁcantly downregulated maternal expression of

Zim1 (Figure 3, 4, and 6). This coincidence might be reﬂecting
the fact that two genes, Peg3 and Zim1, cannot be co-expressed
in cis due to unknown reasons, which could also be the basis
for the opposite imprinting.2 In the normal maternal allele,
Peg3 is repressed through DNA methylation, thus Zim1 can be
expressed. In contrast, the paternal allele of Zim1 cannot be
expressed from the paternal allele due to the expression of
Peg3. In the U1 mutants, Peg3 is now expressed from the
de-repressed maternal allele, which in return causes the downregulation of Zim1 (Figure 6). The exact molecular mechanisms
for this opposite imprinting are currently unknown, but it is
most likely that these two genes may be competing for shared
enhancers. One likely candidate for a shared enhancer is
ECR18. This potential enhancer is localized 200 kb upstream of
Peg3 (Figure 6), and has been shown to interact with several
promoters within the Peg3 domain.18 It should be interesting to
further characterize the detailed mechanisms of this opposite
imprinting of Peg3 and Zim1 in the near future.
Mutants with maternal deletion of U1 provide several insights
regarding the in vivo functions of the mammalian Peg3 domain.
We have seen several cases for the complete loss of Peg3 gene
dosage through mouse KO experiments or complete methylation
on the PEG3-DMR in human cancers.2 However, we have never
observed biallelic expression and subsequent double gene dosage
of Peg3. Until now, mammals with double gene dosage of the
Peg3 domain were assumed to be not viable. The results from the
breeding experiments rather support this prediction in that
females are extremely susceptible to the increased gene dosage of
the Peg3 domain (Figure 5). Although animals with biallelic
expression of Peg3 can be generated in the lab, these mutant animals are extremely unlikely to survive in the wild setting, since
double dosage of the Peg3 domain compromises the survival of
females. It is interesting to note that complete loss or zero dosage
of Peg3, on the other hand, has been shown to cause similar
effects on male, the opposite sex.5 Thus, it is reasonable to
hypothesize that the optimum or tolerable range of gene dosage
of Peg3 may be different in the two sexes. This is reminiscent of
the hypothesis known as ‘intralocus sexual conﬂict,’ in which one
sex favors higher gene dosage whereas the opposite sex favors
lower dosage for a given locus.19 This evolutionary tug-of-war
usually results in different expression levels for a given locus in
each of the two sexes.19 Expression levels of Peg3 are indeed different between the two sexes, being higher in males than
females,20,21 thus supporting the possibility that the mammalian
Peg3 locus may have been subjected to intralocus sexual conﬂict.5
Taken together, the available data strongly suggest the presence
of potential sexual conﬂicts over the Peg3 domain. It is thus likely
that the Peg3 locus might have evolved not only to resolve parental conﬂicts but also to resolve sexual conﬂicts.

Materials and methods
Ethics statement
All the experiments related to mice were performed in
accordance with National Institutes of Health guidelines for
care and use of animals, and also approved by the Louisiana
State University (LSU) Institutional Animal Care and Use
Committee (IACUC), protocol #16-060.
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Generation of the mutant allele deleting the U1
alternative promoter
The 1-kb genomic interval (mm10, chr7:6,750,918-6,751,939)
surrounding the U1 promoter was deleted using a CRISPR/Cas9based scheme described below. Two single-stranded guide RNA
(50 -ATAACAAACGTGTTCAATCCAGGG-30 and 50 -CCTTG
GGTATAATACATAGAGGC-30 ) along with Cas9 mRNA were
injected into the 200 fertilized eggs that had been prepared from
timed mating of C57BL/6J mice. These injected eggs were placed
back to the uterus of the 6 pseudo-pregnant females for the fullterm development, deriving 45 live pups. The subsequent mice
were genotyped to conﬁrm the proper deletion using the following three primers: P1, 50 -TAGCAAGGGAGAGGGCCTAG-30 ;
P2, 50 -GGAAGCCTCCATCCGTTTGT-30 ; P3, 50 -AGCACAGCTAGAAATACACAGA-30 . Some of these founders have been
used for establishing the main deletion line, U1DR, for the current study.
Mouse breeding
The current study used the following breeding schemes: the
maternal and paternal transmission of the U1 deletion through
mating the female and male heterozygotes individually with
male and female wild-type littermates, the inter-crossing
between two heterozygotes, and ﬁnally the crossing between
the female heterozygote and the male homozygotes (Figure 5).
One-day-old pups derived from these breeding experiments
were analyzed in terms of sex, genotype, and body weight. Statistical signiﬁcance of potential difference of litter size and average weight between the breeding experiments was tested using
the X2 test. All the mice were housed at the Division of Lab
Animal Medicine (DLAM) of LSU on a regular 12-12 darklight cycle under a constant temperature of 70 F and 50%
humidity. All animals were given ad libitum access to water
and Rodent Diet 5001. Nursing females were with Mouse Diet
5015. Mice were euthanized by CO2 asphyxiation in accordance
with the rules and regulations set forth by the IACUC. For genotyping, genomic DNA was isolated from either clipped ears or
tail snips by incubating the tissues overnight at 55 C in the lysis
buffer (0.1 M Tris-Cl, pH 8.8, 5 mM EDTA, pH 8.0, 0.2% SDS,
0.2 M NaCl, 20 mg/ml Proteinase K). Isolated DNA was subsequently genotyped using three primers, P1-P3, which were
described above. Sex of the pups was determined by PCR using
the following primer set: mSry-F (50 -GTCCCGTGGTGAGAGGCACAAG-30 ) and mSry-R (50 -GCAGCTCTACTCCA
GTCTTGCC-30 ).
Expression analyses and imprinting tests
Total RNA was isolated from tissues of one-day-old heads
or hypothalamus of adult mice using a commercial kit (Trizol, Invitrogen). Total RNA was then reverse-transcribed
using the M-MuLV Kit (Invitrogen), and the subsequent
cDNA was used as template for qRT-PCR. This analysis
was performed with the iQ SYBR green supermix (Bio-Rad)
using the ViiATM 7 Real-Time PCR System (Life Technologies). All qRT-PCR reactions were carried out for 40 cycles
under standard PCR conditions. The analyses of the results
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derived from qRT-PCR were described previously.22 Statistical signiﬁcance of potential difference of expression levels
of a given gene between two samples was tested with Student’s t-test. The information regarding individual primer
sequences and PCR conditions is available in the previous
study.3,5 For the imprinting test, heterozygotes of the
C57BL/6J background were reciprocally crossed with wild
type mice of the PWD/PhJ background (Jackson Lab, Stock
No. 004660). The F1 hybrid of these crossing was used for
isolating total RNA. The polymorphisms and restriction
enzymes used for each gene imprinting test are also available in the previous study.3,5

DNA methylation analysis
The current study used two types of genomic DNA for DNA
methylation analyses. Mature eggs were isolated using the following method. In brief, three-month-old female mice were
super-ovulated by a series of intraperitoneal hormonal injections. First, 0.1 ml pregnant mare serum gonadotropin (EMD
MilliporeTM , Cat. No. 36-722-21000I) was injected. Second,
0.1 ml human chorionic gonadotropin (Sigma, Cat. No. C1063)
was injected 48 hours later. Ampullae were removed 12 hours
later by gross dissection and placed directly in PBS. Fat was
trimmed away from ampullae under a dissection scope. The
ampullae were then washed in PBS. Under the dissection scope,
ampullae were torn open using a 27-gauge needle and egg sacks
were transferred by mouth pipetting to HCZB solution with
hyaluronidase (Sigma, Cat. No. H3506). After incubating for 30
minutes, oocytes were transferred by mouth pipetting into
clean HCZB/hyaluronidase solution to separate them from
somatic cells. This washing step was repeated 5 times to ensure
the isolation of mature oocytes from somatic cells. Finally, the
recovered oocytes were mouth-pipetted into the lysis buffer
(Tris-HCl pH 8.1 100 mM, EDTA 5 mM, NaCl 200 mM, SDS
0.2%) supplemented with Proteinase K (NEB, Cat. No.
P8107S). For DNA methylation analyses, genomic DNA from
mature eggs or tails was treated with the bisulﬁte conversion
protocol.13 Converted DNA was used as a template for PCR
using the speciﬁc primers that were designed for amplifying
each target region. The ampliﬁed products from mature eggs
were individually cloned into a commercial vector and, on average, 16 clones for each PCR product were sequenced to assess
ﬁnal DNA methylation level. The sequence reads were trimmed
and aligned using Clustal Omega. PCR clones were removed
based on analysis of the phylogenetic tree of aligned sequences.
Ampliﬁed products from tail DNA were analyzed by COBRA.14
Information regarding the sequences of oligonucleotides and
PCR conditions for each target region is also available in the
previous study.3
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